LEIT – Call for Nanotechnologies, Advanced Materials and Production H2020-NMP-CSA-2014 Closed!
Objectives
The Framework Programme for Research and Innovation (2014-2020) is implemented by specific programme and work programmes.
The “Industrial leadership” priority aims to speed up development of the technologies and innovations that will underpin tomorrow's businesses and help innovative European SMEs to grow into world-leading companies. It consists of three specific objectives:
"Leadership in enabling and industrial technologies" provides dedicated support for research, development and demonstration and, where appropriate, for standardisation and certification, on information and communications technology (ICT), nanotechnology, advanced materials, biotechnology, advanced manufacturing and processing and space.
Emphasis is being placed on interactions and convergence across and between the different technologies and their relations to societal challenges. User needs shall be taken into account in all these fields.
1.2 Nanotechnologies
The specific objective of nanotechnologies research and innovation is to secure Union leadership in this high growth global market, by stimulating scientific and technological advancements and investment in nanotechnologies and their uptake in high added value, competitive products and services across a range of applications and sectors.
Actions
Actions foreseen within this call for proposals include the following topics:
- NMP-09-2014: Networking of SMEs in the nano-biomedical sector. Many innovative nano-biomedical developments are initiated by small companies. However, they often miss the necessary knowledge of the regulatory requirements for translation of their ideas, of the market and of the financial aspects of funding the developments and the business. The development and supply chain also show shortcomings. SMEs are often fragmented, dispersed and rarely organised in representative associations to address these problems with the result of missed opportunities for innovation. This is especially true in nanomedicine, covering diagnostics, therapeutics and regenerative medicine.
- NMP-27-2014: Coordination of EU and international efforts in safety of nanotechnology. The development of a novel safety culture for the nanomaterial research and engineering community, and the industry producing engineered nanomaterials and nano-enabled products is a significant challenge in the coming years. Incorporating the safety-by-design as an integral part of the core research activities of nano material sciences and the production of these materials and products would be a major step forward in assuring nanosafety. Such activities are currently on going in the EU and several other industrialised countries in a rather fragmented manner, necessitating specifically oriented action beyond the efforts foreseen in the context of individual projects. The increasing efforts of emerging economies and emerging science countries should also be integrated with the leading actors in the area of nanosafety.
- NMP-31-2014: Novel visualization tools for enhanced nanotechnology awareness. Recent surveys show that the awareness in the public about nanotechnology based products is very low and that awareness without detailed information creates insecurity. In that respect, novel visualization tools are a key element for enhanced communication and improvement of societal understanding of nanotechnology.
- NMP-33-2014: The materials 'common house'. The fragmentation of research efforts has long been identified as a major European weakness. A significant part of national R&D budgets is spent without substantial coordination across the Union, a significant waste of resources at a time of shrinking funding possibilities.
- NMP-36-2014: Facilitating knowledge management, networking and coordination in NMP. The Horizon 2020 programme for the key enabling technologies of nanotechnology, advanced materials and advanced manufacturing and processing needs to function as a catalyst within the larger European Research Area. To be effective, the programme needs to be supported by a knowledge management system capturing the key performance indicators in industrial policy. EU Member States and Associated Countries should be aware how their research systems for enabling and industrial technologies relate with each other and with Horizon 2020, and support is needed for this coordination.
- NMP-37-2014: Practical experience and facilitating combined funding for large-scale RDI initiatives. Industrial investments into research, technological development and innovation in Europe, in particular with the aim to bridge the valley of death and prepare new manufacturing capacities, will often need a combination of funding instruments, including EU, national and regional funding, making use of structural and regional funds, as well as private financing.
European community funding
The Community provisional funding available for the call for proposals is:
- 12,50 Million EUR (Global Budget)
All the important deadlines
- 06 May 2014 - 7 years ago (Deadline for the presentation of proposals)
Further information about the call
Official webpage of the call
Useful documents
Organisations eligible to participate
Opened to the following bodies or institutes with legal status established in the covered areas:
- Any legal organisation
Covered areas
Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:
- European Union (EU)
Directorate-Generale responsible
Directorate-General for Research
Related calls for proposals
- Call for proposals under the work programme of the ECSEL Joint Undertaking
- Call for proposals under the work programme of the ECSEL Joint Undertaking
- Call for proposals 2017 - H2020 - Information and communication technologies
- Call for proposals 2018 for Innovation Actions (IA) under the work programme of the ECSEL Joint Undertaking
- Call for proposals 2020 - IMI-ECSEL Joint Activity complementing the Trials@Home IMI project
Explore other programmes
